LQY-25182-17861
5 vaccinations
3 coded responses
35 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 208 / MD
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-04-06
Dose 2 — Pfizer-BioNTech
-
2021-04-12
Registered in v-safe
- 2021-04-12
- 2021-04-13
- 2021-04-22
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-07-06
- 2021-10-05
-
2021-10-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-11-03
- 2021-11-11
- 2021-11-18
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2022-01-26
-
2022-04-15
Dose 4 — Pfizer-BioNTech
- 2022-04-27
-
2022-04-27
Health check-in — day 7, dose 4Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-05-01
- 2022-05-06
- 2022-05-13
- 2022-05-20
- 2022-05-27
- 2022-07-15
-
2022-09-30
Dose 5 — Pfizer-BioNTech
- 2022-10-07
- 2022-10-14
- 2022-10-23
-
2022-10-28
Survey response — day 28, dose 5MedDRA: Headache, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, congestion, runny nose, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Survey response — day 42, dose 5MedDRA: Cough, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, cough, running roseMedDRA releases: 2024-11 · check-in free text available
-
2023-01-01
Survey response — 3 months, dose 5MedDRA: Respiratory tract congestion — Feeling: GoodMedDRA releases: 2024-11
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-10-27 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-15 | Pfizer-BioNTech | No |
| 5 | 2022-09-30 | Pfizer-BioNTech | No |
Free text
Release 12 — day 28, dose 5
Symptoms: Sore throat, congestion, runny nose, headache
Release 12 — day 42, dose 5
Symptoms: Sore throat, cough, running rose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release